News | March 06, 2026
CordenPharma expands boulder presence with 64,000-Sq-Ft Lease at BioMed Realty’s Flatiron Park
The new LEED Gold-certified building will serve as CordenPharma Colorado’s sole tenant
The new LEED Gold-certified building will serve as CordenPharma Colorado’s sole tenant
Pivya is Alembic’s first branded pharmaceutica product in the US and is being marketed through Alembic Therapeutics LLC
The inspection concluded with zero observations, confirming the facility's compliance with current Good Manufacturing Practices
The funding will be spread over four years, with BXLS also eligible for regulatory and commercial milestones, plus royalties on worldwide sales
Built on the Percept Platform and enhanced with BrainSense technology, the system can adjust stimulation levels in real time, responding to brain signals without manual intervention
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
Emcure to distribute Roche's kidney transplant and anemia drugs in India
The EIR was issued following an inspection of the facility from November 10 to November 21, 2025
Zydus has in-licensed FYB206, a proposed biosimilar to immuno-oncology therapy Keytruda (pembrolizumab), exclusively from Formycon AG for the U.S. and Canadian markets
Zongertinib is setting a new standard as the first targeted therapy for treatment naïve patients with HER2-mutant advanced non-small cell lung cancer with demonstrated efficacy
Subscribe To Our Newsletter & Stay Updated
